Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-announces-first-FDA-filing-acceptance-for-anti-PD-1-antibody-tislelizumab-for-people-with-36407674/?utm_source=whatsapp&utm_medium=social&utm_campaign=share